Skip to content
2000
Volume 1, Issue 2
  • ISSN: 2211-5528
  • E-ISSN:

Abstract

Tumor immune surveillance is the process by which the immune system recognizes and destroys tumor cells, without which cancer would be more frequent among humans. Tumor immune surveillance has long been known to consist of a direct tumor cell lysis component, dependent on the adaptive immune system. New evidence demonstrates that in addition to a direct effect on tumor cells, the immune system regulates tumor growth via regulation of angiogenesis. Many of the cell types of both the innate and adaptive immune system have either pro or anti-angiogenic functions. In this review, we discuss key data for the angiogenesis regulatory role of each of the major immune cell types.

Loading

Article metrics loading...

/content/journals/cag/10.2174/2211552811201020088
2012-06-01
2024-11-30
Loading full text...

Full text loading...

/content/journals/cag/10.2174/2211552811201020088
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test